Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder
Phase: PHASE1 | Sponsor: Trent Emerick | Compound: Psilocybin
- Status
- planned
- Institution
- Trent Emerick
- Start date
- 2026-07-01
- End date
- 2027-08-01
- Registry ID
- NCT07406828
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.